Spiderwort Biotechnologies Inc. Health Canada and PHAC Congrats on hitting this key milestone! 👊

Congratulations to Spiderwort Biotechnologies Inc. a Capital Angel Network #PortfolioCo in this momentous milestone!

Registration is open for the 3rd Annual SCI Investor Symposium. Investors now have an opportunity to connect directly with the teams which are driving innovation and next-generation therapies in SCI. Register and request your 1-on-1 meetings with participating companies today:

Registration is open for the 3rd Annual SCI Investor Symposium. Investors now have an opportunity to connect directly with the teams which are driving innovation and next-generation therapies in SCI. Register and request your 1-on-1 meetings with participating companies today:

From our CEO, Charles M. Cuerrier "Receiving the ITA from Health Canada and PHAC is a critical inflection point in our mission to transform the landscape of regenerative medicine in multiple categories. Hear more about this major milestone ⬇️ ca.finance.yahoo.com/news/spiderwor…

🎉Congratulations to Spiderwort Biotechnologies Inc. on receiving Health Canada’s Investigational Testing Authorization for CelluJuve®! This milestone marks an exciting step forward in regenerative medicine, paving the way for clinical trials in Canada to evaluate the potential of CelluJuve®.

Day 1 of #BIO2025 is here! We've had an incredible response to our Health Canada ITA news for CelluJuve®. Excited to showcase our cellulose-based regenerative medicine platform to the global biotech community. Come find us in Boston! 🧬 ca.finance.yahoo.com/news/spiderwor…

.Lineage Cell Therapeutics and Christopher & Dana Reeve Foundation are excited to announce the initial agenda for the 3rd Annual @SCISymposium! scisymposium.com/2025-agenda/ Presenters are still being added. Reminder to investors to register and request your 1-on-1 meetings with participating companies today:

Day 3 at #BIO2025: From tissue engineering to novel biomaterials, the biotechnology field is advancing rapidly. Here at #Spiderwort, we're excited to be contributing to this space with our cellulose-based approach! Learn more from the team, live in Boston.

Dr. Joely Kaufman, M.D., P.A., FAAD, on #SpiderwortBiotechnologies Health Canada and PHAC ITA, "As a board certified dermatologist with extensive experience in facial aesthetics, I am encouraged by CelluJuve®'s innovative approach to tissue augmentation." spiderwortbio.com/news/spiderwor…

.Lineage Cell Therapeutics and Christopher & Dana Reeve Foundation are excited to announce @Paradromics and Synchron as additional presenters for the 3rd Annual @SCISymposium! scisymposium.com/2025-agenda/ Presenters also include Lineage Cell Therapeutics, @NervGenP, ONWARD Medical, Precision Neuroscience, Spiderwort Biotechnologies Inc.,

We are 3 days away from the SCI Investor Symposium hosted by Lineage Cell Therapeutics and Christopher & Dana Reeve Foundation Investors can register and request their 1-on-1 meetings with participating companies: bit.ly/4e7UbeE Presenters include Lineage Cell Therapeutics, @NervGenP, NurExone Biologic (TSXV: NRX) (Germany: J90), ONWARD Medical,

We are 3 days away from the SCI Investor Symposium hosted by Lineage Cell Therapeutics and Christopher & Dana Reeve Foundation Investors can register and request their 1-on-1 meetings with participating companies: bit.ly/4e7UbeE Presenters include Lineage Cell Therapeutics, @NervGenP, NurExone Biologic (TSXV: NRX) (Germany: J90), ONWARD Medical,

The #ISO 10993 testing completion for CelluJuve®, combined with our recently awarded Health Canada and PHAC ITA, represent critical milestones to validate how cellulose-based tech interacts with human tissue. Safety first, always. spiderwortbio.com/news/spiderwor…

Last week, Dr. Stephen Hanson shared an update on our spinal cord injury treatment progress using #CelluBridge and the Aerocell™ technology platform at the 3rd Annual SCI Investor Symposium. Thank you to the organizers for creating this platform to explore the latest in #SCI treatment.

In case you missed it... Big news via Ottawa Business Journal: We've received Health Canada and PHAC approval to begin human clinical trials for #CelluJuve – our all-natural, cellulose-based alternative to legacy medical aesthetic treatment options. obj.ca/spiderwort-to-…

This is fantastic news for Spiderwort Biotechnologies Inc., #lifesciences and healthcare in Canada (and beyond). Wishing you great success as you enter into human clinical trials here my friends. cc Life Sciences Ontario Clinical Trials ON

Touchdown in Europe. Our cellulose-based platform is opening new doors in regenerative medicine. This week, we're in Vienna and Geneva meeting with strategic partners to explore the future of medical aesthetics.

Behind major breakthroughs is the infra that makes it possible. Our collaboration with LA CITÉ has brought a clean room to life, accelerated development of biotech, and given us the chance to work with passionate researchers. Learn more. collegelacite.ca/innovacite/nos…